Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Biomea Fusion, Inc. (NASDAQ:BMEA) surged 56.8% to $24.20 after the company announced data from the initial cohorts of the ongoing Phase II study of BMF-219 in patients with type 2 diabetes; 100mg cohort 3 demonstrated an 89% response rate and 1% median reduction in HbA1c at day 28.
• Oscar Health, Inc. (NYSE:OSCR) shares jumped 54.9% to $5.54 after the company announced the appointment of healthcare veteran Mark Bertolini as CEO effective April 3, 2023.
• Biodexa Pharmaceuticals (NASDAQ:BDRX) shares jumped 52% to $0.7150 after gaining 65% on Monday.
• Viking Therapeutics, Inc. (NASDAQ:VKTX) gained 46.8% to $13.39 after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of various metabolic disorders.
• Beamr Imaging Ltd. (NASDAQ:BMR) rose 33.3% to $2.9745.
• Mercurity Fintech Holding Inc. (NASDAQ:MFH) surged 26% to $1.7698.
• Bird Global, Inc. (NASDAQ:BRDS) gained 24.4% to $0.17. Bird, on Monday, announced purchases of shares by management and directors.
• ZW Data Action Technologies Inc. (NASDAQ:CNET) gained 23.5% to $2.15. ZW Data Action Technologies entered into cooperation agreement with Chaineffect (Guangzhou) Blockchain Technology.
• Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) shares surged 20% to $57.48 after the company announced topline results from Study 403 evaluating lumateperone as monotherapy in patients with major depressive disorder with mixed features and bipolar depression with mixed features.
• PVH Corp. (NYSE:PVH) rose 19% to $87.57 after the company posted better-than-expected results for its fourth quarter and issued strong FY23 earnings forecast.
• Guardion Health Sciences, Inc. (NASDAQ:GHSI) climbed 18.3% to $7.38.
• Milestone Pharmaceuticals Inc. (NASDAQ:MIST) gained 15.3% to $4.1506. Milestone Pharmaceuticals announced a $125 million strategic funding with an existing shareholder.
• The Lovesac Company (NASDAQ:LOVE) rose 14.7% to $27.52 after the company announced better-than-expected Q4 EPS and sales results and issued FY24 EPS and sales guidance above estimates.
• Silvergate Capital Corporation (NYSE:SI) shares rose 13.7% to $2.24. Silvergate Capital shares gained around 15% on Monday after MacroStrategy reported it voluntarily prepaid its Silvergate Bank loan. MicroStrategy prepaid approximately $161.0 million.
• McCormick & Company, Incorporated (NYSE:MKC) gained 12.2% to $83.14. McCormick & Co reported first-quarter FY23 sales growth of 3% year-on-year to $1.57 billion, beating the consensus of $1.54 billion.
• Purple Innovation, Inc. (NASDAQ:PRPL) surged 11.8% to $2.8085.
• IHS Holding Limited (NYSE:IHS) jumped 11.6% to $7.92 following Q4 results.
• Standard Lithium Ltd. (NYSE:SLI) gained 10.9% to $3.6385.
• Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares rose 9.9% to $1.11. Cidara Therapeutics President and CEO Jeffrey Stein acquired a total 50,000 shares at an average price of $1.04.
• Alibaba Group Holding Limited (NYSE:BABA) gained 8.3% to $93.31 following a report suggesting the company will be splitting into six units that may pursue individual IPOs.
• Proterra Inc. (NASDAQ:PTRA) gained 8.3% to $1.57.

Losers

• Monopar Therapeutics Inc. (NASDAQ:MNPR) shares declined 49.8% to $1.4890 after the company announced it will be discontinuing its Validive Phase 2b/3 VOICE trial along with the active development of Validive after the company was informed the trial didn't meet the pre-defined threshold for efficacy.
• Virgin Orbit Holdings, Inc. (NASDAQ:VORB) shares dropped 27% to $ 0.39. Virgin Orbit is extending its pause in operation to pursue investment, CNBC reported, citing a company-wide mail by CEO Dan Hart.
• Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) fell 26.4% to $30.53 after Scorpion Capital issued a short report on the company.
• WiSA Technologies, Inc. (NASDAQ:WISA) fell 25.7% to $2.67 after jumping around 89% on Monday.
• OncoSec Medical Incorporated (NASDAQ:ONCS) shares fell 20.5% to $2.10.
• TRxADE HEALTH, Inc. (NASDAQ:MEDS) dropped 20.3% to $0.3625 following a wider-than-expected quarterly loss.
• Draganfly Inc. (NASDAQ:DPRO) fell 18.2% to $1.43 after posting a loss for the fourth quarter.
• Better Choice Company Inc. (NYSE:BTTR) dropped 16.6% to $0.3701 following weak quarterly sales.
• Boxed, Inc. (NYSE:BOXD) declined 14.3% to $0.1740.
• Allarity Therapeutics, Inc. (NASDAQ:ALLR) dropped 12.8% to $2.2399. Allarity Therapeutics said that for Ixempra and stenoparib monotherapy trials, Allarity is taking steps to accelerate patient recruitment to support the goals for interim data readouts by the end of 2023.
• Finch Therapeutics Group, Inc. (NASDAQ:FNCH) fell 12.5% to $0.35. Finch Therapeutics Group recently posted a Q4 loss of $0.56 per share.
• iHeartMedia, Inc. (NASDAQ:IHRT) dipped 11.6% to $3.79. B of A Securities downgraded iHeartMedia from Neutral to Underperform and lowered the price target from $6.5 to $4.
• Puyi Inc. (NASDAQ:PUYI) fell 11.2% to $5.77.
• CytomX Therapeutics, Inc. (NASDAQ:CTMX) fell 10.1% to $1.61 after the company posted results for its fourth quarter.
• BM Technologies, Inc. (NASDAQ:BMTX) dropped 9.6% to $3.48 following weak quarterly sales.
• Invesco Mortgage Capital Inc. (NYSE:IVR) fell 5% to $10.64 after the company announced a cash dividend of $0.40 per share of common stock for the first quarter and issued an update on estimated results of operations, portfolio, liquidity and book value.

Now Read This: Bitcoin Falls Below $27,000; Mina, Arbitrum Among Top Losers